Human Urinary Kallidinogenase: Clinical Trials

6 trials of Human Urinary Kallidinogenase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 not yet recruiting, 1 recruiting. 2 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Not yet recruiting 2
Phase 22Completed 1, Recruiting 1
Phase 11Completed 1
Phase 41Completed 1

Follow Human Urinary Kallidinogenase: new trials by email Literature Review of Human Urinary Kallidinogenase trials Research Report on Human Urinary Kallidinogenase

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Human Urinary Kallidinogenase Combined With Reteplase Intravenous Thrombolysis in the Treatment of Acute Ischemic Stroke
Human Urinary Kallidinogenase, Clinical Routine Treatment - Acute Ischemic Stroke
Not applicableNot yet recruitingChina-Japan Union Hospital2202026-05-012026-03-30
Tenecteplase Plus Urinary Kallidinogenase for Acute Ischemic Stroke (TUKIS)
Human Urinary Kallidinogenase - Ischemic Stroke
Phase 2RecruitingGeneral Hospital of Shenyang Military Region2002026-01-202026-01-23
Effects of Human Urinary Kallidinogenase on Early Improvement and Functional Outcomes in Acute Ischemic Stroke (TK-SPEED)
Human Urinary Kallidinogenase, Clinical Routine Treatment - Acute Ischemic Stroke, Functional Outcomes
Not applicableNot yet recruitingBeijing Tsinghua Chang Gung Hospital5402023-12-142023-12-06
Study to Assess PK, Safety and Tolerability in Healthy Subjects
QHRD106 Injection, Human Urinary Kallidinogenase, placebo - Acute Ischemic Stroke
Phase 1CompletedChangzhou Qianhong Bio-pharma Co., Ltd.562023-03-162024-07-24
Human Urinary Kallidinogenase Improve Short Term Motor Functional Outcome of Acute Ischemia Stroke Patients
Kallikrein - Stroke, Acute
Phase 4CompletedThe Second Hospital of Hebei Medical University802017-07-012021-03-01
Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase
Human Urinary Kallidinogenase, Shuxuening injection - Cerebral Infarction
Phase 2CompletedXuanwuH 21202013-01-012014-10-08

Conditions studied

Ischemic Stroke (4)  ·  Cerebral Infarction (1)  ·  Stroke (1)

Sponsors

Beijing Tsinghua Chang Gung Hospital (1)  ·  Changzhou Qianhong Bio-pharma Co., Ltd. (1)  ·  China-Japan Union Hospital (1)  ·  General Hospital of Shenyang Military Region (1)  ·  The Second Hospital of Hebei Medical University (1)  ·  XuanwuH 2 (1)

Countries

China (5)

Top investigators

Jian Wu (1)  ·  Juan Li, Doctor (1)  ·  Xiaoyun Liu, Prf. (1)  ·  Zunjing Liu (1)

Results publications

PMID 38526971, PMID 39545461, PMID 42716572